Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril-valsartan versus enalapril for blood pressure control in intracerebral hemorrhage
IRCT20260217068896N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of sacubitril + valsartan and enalapril in hypertension (HTN) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Systolic blood pressure and Diastolic blood pressure. Started Feb 2026; status: completed.
02
Drugs
sacubitril + valsartanenalapril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20260217068896N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260217068896N1.